A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain malignancy known for its fast growth and insensitivity to standard treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in gliobla